Hollie Franklin, Author at Drugs in Context

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges

Shinichi Makita MD, PhD, Katsuaki Imaizumi Ph, Saiko Kurosawa MD, Kensei Tobinai MD, PhD

Article Type

Review

Published

13 Feb 2019

In this review, the recent clinical developments, clinical implications, and perspectives of CAR T-cell therapy are summarized, focusing on B-cell NHL

Oral oncolytic and antiretroviral therapy administration: dose adjustments, drug interactions, and other considerations for clinical use

Melissa E Badowski PharmD, MPH, Bradley Burton PharmD, Kristy M Shaeer PharmD, MPH, John Dicristofano BS, PharmD Candidate

Article Type

Review

Published

13 Feb 2019

This article evaluates existing literature through such means as drug databases and package inserts along with PubMed/Medline, Embase, and Google Scholar databases to develop a reference tool for providers to utilize when there is a decision to treat a patient with ART and oral oncolytic agents concurrently.

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports

José Alexandre Mendonça PhD, Guilherme B Damian MD

Article Type

Case Report

Published

13 Feb 2019

This series of case reports demonstrates the
efficacy of certolizumab pegol in patients with rheumatoid arthritis using gray scale
and power Doppler ultrasonography to monitor disease progression.

Medication adherence and treatment-resistant hypertension: a review

Mohammed Awais Hameed MB, ChB, Indranil Dasgupta DM

Article Type

Review

Published

04 Feb 2019

This article reviews medication nonadherence
in chronic health conditions with particular reference to
treatment-resistant hypertension.

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA

Alpesh Amin MD, MBA, W Richey Neuman MD, MPH, Melissa Lingohr-Smith PhD, Brandy Menges PhD, Jay Lin PhD, MBA

Article Type

Original Research

Published

21 Jan 2019

This article evaluates whether the duration of hospital stay influences venous thromboembolism (VTE) prophylaxis patterns and VTE risk during hospitalization and post-discharge among patients hospitalized for acute illnesses in the USA.